The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapy-Reference-Cited by-同舟云学术

The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapy

Published:2020-03-06 Issue:8 Volume:27 Page:2433-2450
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Yang Bo,Zhang Bin,Cao Zhifei,Xu Xingdong,Huo Zihe,Zhang Pan,Xiang Shufen,Zhao Zhe,Lv Chunping,Meng Mei,Zhang Gaochuan,Dong Liang,Shi Shucheng,Yang Lan,Zhou Quansheng

Funder

the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/s41418-020-0514-3.pdf

Reference67 articles.

1. Khanna A. DNA damage in cancer therapeutics: a boon or a curse. Cancer Res 2015;75:2133–38.

2. Basu AK. DNA damage, mutagenesis and cancer. Int J Mol Sci. 2018;19:pii: E970.

3. Desai A, Yan Y, Gerson SL. Advances in therapeutic targeting of the DNA damage response in cancer. DNA Repair (Amst). 2018;66-67:24–9.